Display options
Cite
Zhang H, Shen WJ, Li Y, et al. Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats. Nutr Metab (Lond). 2016;13:63doi: 10.1186/s12986-016-0121-y.
Zhang, H., Shen, W. J., Li, Y., Bittner, A., Bittner, S., Tabassum, J., Cortez, Y. F., Kraemer, F. B., & Azhar, S. (2016). Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats. Nutrition & metabolism, 1363. https://doi.org/10.1186/s12986-016-0121-y
Zhang, Haiyan, et al. "Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats." Nutrition & metabolism vol. 13 (2016): 63. doi: https://doi.org/10.1186/s12986-016-0121-y
Zhang H, Shen WJ, Li Y, Bittner A, Bittner S, Tabassum J, Cortez YF, Kraemer FB, Azhar S. Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats. Nutr Metab (Lond). 2016 Sep 29;13:63. doi: 10.1186/s12986-016-0121-y. eCollection 2016. PMID: 27708683; PMCID: PMC5041401.
Copy Download .nbib Format: NLM
Share it on

Nutr Metab (Lond). 2016 Sep 29;13:63. doi: 10.1186/s12986-016-0121-y. eCollection 2016.

Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats.

Nutrition & metabolism

Haiyan Zhang, Wen-Jun Shen, Yihang Li, Alex Bittner, Stefanie Bittner, Juveria Tabassum, Yuan F Cortez, Fredric B Kraemer, Salman Azhar

Affiliations

  1. Geriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, CA USA ; Division of Endocrinology, Stanford University, Stanford, CA USA ; Present Address: Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033 USA.
  2. Geriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, CA USA ; Division of Endocrinology, Stanford University, Stanford, CA USA.
  3. Geriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, CA USA ; Division of Endocrinology, Stanford University, Stanford, CA USA ; Present Address: Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, MO USA.
  4. Geriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, CA USA.

PMID: 27708683 PMCID: PMC5041401 DOI: 10.1186/s12986-016-0121-y

Abstract

Nordihydroguaiaretic acid (NDGA), the main metabolite of Creosote Bush, has been shown to have profound effects on the core components of metabolic syndrome, including lowering of blood glucose, free fatty acids and triglyceride levels, attenuating elevated blood pressure in several rodent models of dyslipidemia, and improving body weight, insulin resistance, diabetes and hypertension. In the present study, a high-fructose diet fed rat model of hypertriglyceridemia, dyslipidemia, insulin resistance and hepatic steatosis was employed to investigate the global transcriptional changes in the lipid metabolizing pathways in three insulin sensitive tissues: liver, skeletal muscle and adipose tissue in response to chronic dietary administration of NDGA. Sprague-Dawley male rats (SD) were fed a chow (control) diet, high-fructose diet (HFrD) or HFrD supplemented with NDGA (2.5 g/kg diet) for eight weeks. Dietary administration of NDGA decreased plasma levels of TG, glucose, and insulin, and attenuated hepatic TG accumulation. DNA microarray expression profiling indicated that dietary administration of NDGA upregulated the expression of certain genes involved in fatty acid oxidation and their transcription regulator, PPARα, decreased the expression of a number of lipogenic genes and relevant transcription factors, and differentially impacted the genes of fatty acid transporters, acetyl CoA synthetases, elongases, fatty acid desaturases and lipid clearance proteins in liver, skeletal muscle and adipose tissues. These findings suggest that NDGA ameliorates hypertriglyceridemia and steatosis primarily by inhibiting lipogenesis and enhancing fatty acid catabolism in three major insulin responsive tissues by altering the expression of key enzyme genes and transcription factors involved in de novo lipogenesis and fatty acid oxidation.

Keywords: CD36; Fatty acid oxidation; Hypertriglyceridemia; L-FABP; Lipogenesis; Malony-CoA decarboxylase; Steatosis

References

  1. N Engl J Med. 2010 Sep 30;363(14 ):1341-50 - PubMed
  2. Nat Rev Gastroenterol Hepatol. 2010 May;7(5):251-64 - PubMed
  3. Eur J Biochem. 1997 Feb 15;244(1):1-14 - PubMed
  4. J Nutr Biochem. 2012 Mar;23(3):203-8 - PubMed
  5. Biochem Biophys Res Commun. 2010 Oct 8;401(1):92-7 - PubMed
  6. Hepatology. 2003 Apr;37(4):917-23 - PubMed
  7. Biochim Biophys Acta. 2000 Jun 26;1486(1):1-17 - PubMed
  8. Biochem J. 2004 Mar 15;378(Pt 3):983-90 - PubMed
  9. Pharmacol Biochem Behav. 2010 Nov;97(1):101-6 - PubMed
  10. Am J Physiol Endocrinol Metab. 2000 Sep;279(3):E593-600 - PubMed
  11. Ann Med. 2011 Dec;43(8):617-49 - PubMed
  12. PLoS One. 2012;7(2):e31812 - PubMed
  13. Adv Nutr. 2013 Mar 01;4(2):226-35 - PubMed
  14. J Biol Chem. 2008 Nov 14;283(46):31333-40 - PubMed
  15. Hepatology. 2013 Jun;57(6):2525-31 - PubMed
  16. J Clin Invest. 2006 Mar;116(3):571-80 - PubMed
  17. Endocr Rev. 2013 Feb;34(1):84-129 - PubMed
  18. Pediatr Obes. 2013 Aug;8(4):242-8 - PubMed
  19. PLoS One. 2015 Sep 22;10(9):e0138203 - PubMed
  20. Ann Hepatol. 2009;8 Suppl 1:S18-24 - PubMed
  21. Am J Physiol Gastrointest Liver Physiol. 2013 Jan 1;304(1):G72-86 - PubMed
  22. Reprod Toxicol. 2009 Jun;27(3-4):246-57 - PubMed
  23. Curr Opin Lipidol. 2014 Feb;25(1):61-6 - PubMed
  24. Nat Rev Endocrinol. 2011 May 10;7(8):456-65 - PubMed
  25. J Appl Physiol (1985). 1996 Jan;80(1):261-70 - PubMed
  26. Am J Hypertens. 1999 Jul;12(7):744-6 - PubMed
  27. World J Gastroenterol. 2014 Oct 7;20(37):13306-24 - PubMed
  28. Am J Clin Nutr. 2009 Jun;89(6):1760-5 - PubMed
  29. PLoS One. 2011;6(7):e22544 - PubMed
  30. Cell Res. 2010 Feb;20(2):124-37 - PubMed
  31. Compr Physiol. 2013 Oct;3(4):1493-532 - PubMed
  32. Cell Metab. 2005 Feb;1(2):133-44 - PubMed
  33. Semin Liver Dis. 2013 Nov;33(4):301-11 - PubMed
  34. Circulation. 2009 Oct 20;120(16):1640-5 - PubMed
  35. Ann Intern Med. 2005 Nov 15;143(10 ):722-8 - PubMed
  36. Diabetologia. 1999 Jan;42(1):102-6 - PubMed
  37. J Clin Invest. 2006 Mar;116(3):581-9 - PubMed
  38. Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):629-36 - PubMed
  39. Minerva Gastroenterol Dietol. 2013 Mar;59(1):69-87 - PubMed
  40. J Nutr. 2008 Jun;138(6):1039-46 - PubMed
  41. BMC Evol Biol. 2013 Dec 12;13:271 - PubMed
  42. J Biol Chem. 2002 Jul 19;277(29):26089-97 - PubMed
  43. J Nutr. 2009 Jun;139(6):1228S-1235S - PubMed
  44. J Gastroenterol. 2013 Apr;48(4):434-41 - PubMed
  45. Diabetes Care. 2013 Jan;36(1):150-6 - PubMed
  46. Nat Rev Endocrinol. 2013 Jan;9(1):13-27 - PubMed
  47. J Clin Invest. 2002 May;109(9):1125-31 - PubMed
  48. JAMA. 2010 Apr 21;303(15):1490-7 - PubMed
  49. J Clin Invest. 2009 May;119(5):1322-34 - PubMed
  50. Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112 - PubMed
  51. PPAR Res. 2010;2010:null - PubMed
  52. Cell Metab. 2006 Aug;4(2):107-10 - PubMed
  53. Am J Clin Nutr. 1993 Nov;58(5 Suppl):737S-747S - PubMed
  54. World J Gastroenterol. 2014 Feb 21;20(7):1756-67 - PubMed
  55. Crit Rev Clin Lab Sci. 2011 May-Jun;48(3):97-113 - PubMed
  56. J Nutr. 2011 Nov;141(11):2003-9 - PubMed
  57. Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):686-90 - PubMed
  58. Curr Opin Cardiol. 2012 Jul;27(4):420-8 - PubMed
  59. Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):656-65 - PubMed
  60. Nutrients. 2014 Dec 10;6(12 ):5679-703 - PubMed
  61. World J Gastroenterol. 2008 Jan 14;14(2):185-92 - PubMed
  62. Cell Metab. 2012 Feb 8;15(2):240-6 - PubMed
  63. Pharmacol Rev. 2009 Sep;61(3):373-93 - PubMed
  64. Nat Med. 2004 Mar;10(3):268-74 - PubMed
  65. J Biol Chem. 2002 Sep 6;277(36):32571-7 - PubMed
  66. Annu Rev Pathol. 2010;5:145-71 - PubMed
  67. Gastroenterology. 2012 Jun;142(7):1592-609 - PubMed
  68. J Lipid Res. 2002 Aug;43(8):1220-35 - PubMed
  69. J Biol Chem. 1957 May;226(1):497-509 - PubMed
  70. J Ethnopharmacol. 2005 Apr 26;98(3):231-9 - PubMed
  71. Prog Lipid Res. 2014 Jan;53:124-44 - PubMed
  72. Aliment Pharmacol Ther. 2011 Aug;34(3):274-85 - PubMed
  73. Endocrinology. 2004 Feb;145(2):548-55 - PubMed
  74. Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4320-5 - PubMed
  75. Annu Rev Biochem. 2008;77:289-312 - PubMed
  76. J Biol Chem. 2002 Feb 8;277(6):4098-103 - PubMed
  77. Nucl Recept Signal. 2010 Apr 16;8:e002 - PubMed
  78. Biochem J. 2002 Sep 1;366(Pt 2):377-91 - PubMed
  79. Trends Endocrinol Metab. 2011 Feb;22(2):60-5 - PubMed
  80. J Biol Chem. 2014 Apr 18;289(16):10989-98 - PubMed
  81. Curr Opin Clin Nutr Metab Care. 2013 Jul;16(4):446-52 - PubMed
  82. Am J Clin Nutr. 1989 Jun;49(6):1155-63 - PubMed
  83. Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):676-85 - PubMed
  84. Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):637-53 - PubMed
  85. Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44 - PubMed
  86. J Biol Chem. 2000 Aug 11;275(32):24279-83 - PubMed
  87. Biochem J. 2014 May 1;459(3):551-64 - PubMed
  88. J Appl Physiol (1985). 2011 Dec;111(6):1828-35 - PubMed
  89. Science. 2011 Jun 24;332(6037):1519-23 - PubMed
  90. J Biol Chem. 2006 Sep 29;281(39):28721-30 - PubMed
  91. Obes Rev. 2015 Jan;16(1):1-12 - PubMed

Publication Types

Grant support